nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.165	0.203	CrCrCtD
Carbidopa—Levonordefrin—Salbutamol—chronic obstructive pulmonary disease	0.155	0.19	CrCrCtD
Carbidopa—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.134	0.165	CrCrCtD
Carbidopa—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.134	0.165	CrCrCtD
Carbidopa—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.125	0.153	CrCrCtD
Carbidopa—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.102	0.125	CrCrCtD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00336	0.223	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00274	0.182	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—APIP—chronic obstructive pulmonary disease	0.00109	0.0723	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000983	0.0652	CbGpPWpGaD
Carbidopa—Mesalazine—MPO—chronic obstructive pulmonary disease	0.000949	0.195	CrCbGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000714	0.0474	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000652	0.0433	CbGpPWpGaD
Carbidopa—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.0005	0.103	CrCbGaD
Carbidopa—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.000455	0.0934	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000453	0.0301	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.000432	0.0287	CbGpPWpGaD
Carbidopa—Epinephrine—TNF—chronic obstructive pulmonary disease	0.000431	0.0885	CrCbGaD
Carbidopa—Norepinephrine—ADRB2—chronic obstructive pulmonary disease	0.000421	0.0864	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000409	0.0272	CbGpPWpGaD
Carbidopa—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	0.00039	0.0801	CrCbGaD
Carbidopa—Epinephrine—ADRB2—chronic obstructive pulmonary disease	0.000382	0.0784	CrCbGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GCLC—chronic obstructive pulmonary disease	0.000379	0.0252	CbGpPWpGaD
Carbidopa—Dopamine—SLC6A4—chronic obstructive pulmonary disease	0.000356	0.073	CrCbGaD
Carbidopa—Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000348	0.0715	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000334	0.0222	CbGpPWpGaD
Carbidopa—Dopamine—CYP1A2—chronic obstructive pulmonary disease	0.000324	0.0664	CrCbGaD
Carbidopa—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.0649	CrCbGaD
Carbidopa—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00031	0.0019	CcSEcCtD
Carbidopa—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.00188	CcSEcCtD
Carbidopa—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00188	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000307	0.0204	CbGpPWpGaD
Carbidopa—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000306	0.00187	CcSEcCtD
Carbidopa—Cough—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00187	CcSEcCtD
Carbidopa—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00187	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000305	0.0203	CbGpPWpGaD
Carbidopa—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00186	CcSEcCtD
Carbidopa—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00186	CcSEcCtD
Carbidopa—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000303	0.00185	CcSEcCtD
Carbidopa—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00185	CcSEcCtD
Carbidopa—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00185	CcSEcCtD
Carbidopa—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00185	CcSEcCtD
Carbidopa—Cough—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00183	CcSEcCtD
Carbidopa—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00183	CcSEcCtD
Carbidopa—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00183	CcSEcCtD
Carbidopa—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00183	CcSEcCtD
Carbidopa—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00183	CcSEcCtD
Carbidopa—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00182	CcSEcCtD
Carbidopa—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.0018	CcSEcCtD
Carbidopa—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000295	0.0018	CcSEcCtD
Carbidopa—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00179	CcSEcCtD
Carbidopa—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00179	CcSEcCtD
Carbidopa—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00179	CcSEcCtD
Carbidopa—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00178	CcSEcCtD
Carbidopa—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00178	CcSEcCtD
Carbidopa—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00177	CcSEcCtD
Carbidopa—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00177	CcSEcCtD
Carbidopa—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00175	CcSEcCtD
Carbidopa—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00175	CcSEcCtD
Carbidopa—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00175	CcSEcCtD
Carbidopa—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00174	CcSEcCtD
Carbidopa—Infection—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00174	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000284	0.0188	CbGpPWpGaD
Carbidopa—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00172	CcSEcCtD
Carbidopa—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00172	CcSEcCtD
Carbidopa—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00172	CcSEcCtD
Carbidopa—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00171	CcSEcCtD
Carbidopa—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00171	CcSEcCtD
Carbidopa—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.0017	CcSEcCtD
Carbidopa—Infection—Montelukast—chronic obstructive pulmonary disease	0.000278	0.0017	CcSEcCtD
Carbidopa—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00169	CcSEcCtD
Carbidopa—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00169	CcSEcCtD
Carbidopa—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00168	CcSEcCtD
Carbidopa—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00168	CcSEcCtD
Carbidopa—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00166	CcSEcCtD
Carbidopa—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00165	CcSEcCtD
Carbidopa—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00164	CcSEcCtD
Carbidopa—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00164	CcSEcCtD
Carbidopa—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00164	CcSEcCtD
Carbidopa—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00163	CcSEcCtD
Carbidopa—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00163	CcSEcCtD
Carbidopa—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00162	CcSEcCtD
Carbidopa—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.0016	CcSEcCtD
Carbidopa—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.0016	CcSEcCtD
Carbidopa—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00158	CcSEcCtD
Carbidopa—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00158	CcSEcCtD
Carbidopa—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00158	CcSEcCtD
Carbidopa—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00157	CcSEcCtD
Carbidopa—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000256	0.00157	CcSEcCtD
Carbidopa—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00156	CcSEcCtD
Carbidopa—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00156	CcSEcCtD
Carbidopa—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00156	CcSEcCtD
Carbidopa—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00156	CcSEcCtD
Carbidopa—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00155	CcSEcCtD
Carbidopa—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00154	CcSEcCtD
Carbidopa—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00154	CcSEcCtD
Carbidopa—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00154	CcSEcCtD
Carbidopa—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00154	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000251	0.0167	CbGpPWpGaD
Carbidopa—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00153	CcSEcCtD
Carbidopa—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00152	CcSEcCtD
Carbidopa—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.00152	CcSEcCtD
Carbidopa—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00152	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Carbidopa—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00151	CcSEcCtD
Carbidopa—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00151	CcSEcCtD
Carbidopa—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00151	CcSEcCtD
Carbidopa—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.0015	CcSEcCtD
Carbidopa—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.0015	CcSEcCtD
Carbidopa—Pain—Formoterol—chronic obstructive pulmonary disease	0.000244	0.0015	CcSEcCtD
Carbidopa—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000244	0.0015	CcSEcCtD
Carbidopa—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00149	CcSEcCtD
Carbidopa—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00148	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00148	CcSEcCtD
Carbidopa—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00148	CcSEcCtD
Carbidopa—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00147	CcSEcCtD
Carbidopa—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00147	CcSEcCtD
Carbidopa—Pain—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00147	CcSEcCtD
Carbidopa—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00147	CcSEcCtD
Carbidopa—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000239	0.00146	CcSEcCtD
Carbidopa—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00146	CcSEcCtD
Carbidopa—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00146	CcSEcCtD
Carbidopa—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Carbidopa—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00145	CcSEcCtD
Carbidopa—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.00145	CcSEcCtD
Carbidopa—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.00145	CcSEcCtD
Carbidopa—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00144	CcSEcCtD
Carbidopa—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00144	CcSEcCtD
Carbidopa—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00144	CcSEcCtD
Carbidopa—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00144	CcSEcCtD
Carbidopa—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00143	CcSEcCtD
Carbidopa—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00143	CcSEcCtD
Carbidopa—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00143	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00143	CcSEcCtD
Carbidopa—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00142	CcSEcCtD
Carbidopa—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00141	CcSEcCtD
Carbidopa—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00141	CcSEcCtD
Carbidopa—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000229	0.0014	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0014	CcSEcCtD
Carbidopa—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00139	CcSEcCtD
Carbidopa—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00139	CcSEcCtD
Carbidopa—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Carbidopa—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Carbidopa—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Carbidopa—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00138	CcSEcCtD
Carbidopa—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00138	CcSEcCtD
Carbidopa—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00137	CcSEcCtD
Carbidopa—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00137	CcSEcCtD
Carbidopa—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00137	CcSEcCtD
Carbidopa—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000223	0.00137	CcSEcCtD
Carbidopa—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00136	CcSEcCtD
Carbidopa—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00136	CcSEcCtD
Carbidopa—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00136	CcSEcCtD
Carbidopa—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00136	CcSEcCtD
Carbidopa—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00136	CcSEcCtD
Carbidopa—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00135	CcSEcCtD
Carbidopa—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00134	CcSEcCtD
Carbidopa—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00133	CcSEcCtD
Carbidopa—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00131	CcSEcCtD
Carbidopa—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00131	CcSEcCtD
Carbidopa—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00131	CcSEcCtD
Carbidopa—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00129	CcSEcCtD
Carbidopa—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00129	CcSEcCtD
Carbidopa—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00129	CcSEcCtD
Carbidopa—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00126	CcSEcCtD
Carbidopa—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00126	CcSEcCtD
Carbidopa—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00126	CcSEcCtD
Carbidopa—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00124	CcSEcCtD
Carbidopa—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00124	CcSEcCtD
Carbidopa—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00123	CcSEcCtD
Carbidopa—DDC—Metabolism—APIP—chronic obstructive pulmonary disease	0.0002	0.0133	CbGpPWpGaD
Carbidopa—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00122	CcSEcCtD
Carbidopa—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00121	CcSEcCtD
Carbidopa—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0012	CcSEcCtD
Carbidopa—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0012	CcSEcCtD
Carbidopa—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00119	CcSEcCtD
Carbidopa—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00118	CcSEcCtD
Carbidopa—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00117	CcSEcCtD
Carbidopa—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00117	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.00019	0.0126	CbGpPWpGaD
Carbidopa—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00116	CcSEcCtD
Carbidopa—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00116	CcSEcCtD
Carbidopa—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00113	CcSEcCtD
Carbidopa—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00113	CcSEcCtD
Carbidopa—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Carbidopa—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00111	CcSEcCtD
Carbidopa—Rash—Formoterol—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Carbidopa—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Carbidopa—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Carbidopa—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Carbidopa—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00018	0.0011	CcSEcCtD
Carbidopa—Headache—Formoterol—chronic obstructive pulmonary disease	0.000179	0.0011	CcSEcCtD
Carbidopa—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.0011	CcSEcCtD
Carbidopa—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000179	0.0011	CcSEcCtD
Carbidopa—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00109	CcSEcCtD
Carbidopa—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00109	CcSEcCtD
Carbidopa—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00109	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000177	0.0118	CbGpPWpGaD
Carbidopa—Rash—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00108	CcSEcCtD
Carbidopa—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00108	CcSEcCtD
Carbidopa—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00108	CcSEcCtD
Carbidopa—Depression—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00108	CcSEcCtD
Carbidopa—Headache—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00107	CcSEcCtD
Carbidopa—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00106	CcSEcCtD
Carbidopa—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00106	CcSEcCtD
Carbidopa—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00106	CcSEcCtD
Carbidopa—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00106	CcSEcCtD
Carbidopa—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00105	CcSEcCtD
Carbidopa—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00105	CcSEcCtD
Carbidopa—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00104	CcSEcCtD
Carbidopa—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00104	CcSEcCtD
Carbidopa—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00104	CcSEcCtD
Carbidopa—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00104	CcSEcCtD
Carbidopa—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00104	CcSEcCtD
Carbidopa—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00104	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00102	CcSEcCtD
Carbidopa—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00102	CcSEcCtD
Carbidopa—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00101	CcSEcCtD
Carbidopa—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.001	CcSEcCtD
Carbidopa—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000982	CcSEcCtD
Carbidopa—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000977	CcSEcCtD
Carbidopa—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000975	CcSEcCtD
Carbidopa—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00097	CcSEcCtD
Carbidopa—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000965	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000155	0.0103	CbGpPWpGaD
Carbidopa—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000948	CcSEcCtD
Carbidopa—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000933	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000916	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000149	0.00992	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000149	0.00987	CbGpPWpGaD
Carbidopa—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000147	0.0009	CcSEcCtD
Carbidopa—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000857	CcSEcCtD
Carbidopa—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000857	CcSEcCtD
Carbidopa—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000851	CcSEcCtD
Carbidopa—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000849	CcSEcCtD
Carbidopa—DDC—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000132	0.00879	CbGpPWpGaD
Carbidopa—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000811	CcSEcCtD
Carbidopa—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000795	CcSEcCtD
Carbidopa—DDC—Metabolism—GC—chronic obstructive pulmonary disease	0.000129	0.00855	CbGpPWpGaD
Carbidopa—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000783	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000781	CcSEcCtD
Carbidopa—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00078	CcSEcCtD
Carbidopa—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000776	CcSEcCtD
Carbidopa—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000771	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000126	0.00836	CbGpPWpGaD
Carbidopa—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000761	CcSEcCtD
Carbidopa—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000757	CcSEcCtD
Carbidopa—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000753	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000742	CcSEcCtD
Carbidopa—DDC—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00012	0.00795	CbGpPWpGaD
Carbidopa—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000731	CcSEcCtD
Carbidopa—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000729	CcSEcCtD
Carbidopa—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000716	CcSEcCtD
Carbidopa—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00071	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000698	CcSEcCtD
Carbidopa—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000689	CcSEcCtD
Carbidopa—Infection—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000684	CcSEcCtD
Carbidopa—Shock—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000678	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000666	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000108	0.00716	CbGpPWpGaD
Carbidopa—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000657	CcSEcCtD
Carbidopa—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000627	CcSEcCtD
Carbidopa—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000623	CcSEcCtD
Carbidopa—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000619	CcSEcCtD
Carbidopa—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000606	CcSEcCtD
Carbidopa—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000599	CcSEcCtD
Carbidopa—Rash—Prednisolone—chronic obstructive pulmonary disease	9.76e-05	0.000598	CcSEcCtD
Carbidopa—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.000597	CcSEcCtD
Carbidopa—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000594	CcSEcCtD
Carbidopa—Headache—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000594	CcSEcCtD
Carbidopa—Constipation—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000589	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000568	CcSEcCtD
Carbidopa—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000563	CcSEcCtD
Carbidopa—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.2e-05	0.000563	CcSEcCtD
Carbidopa—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000547	CcSEcCtD
Carbidopa—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000545	CcSEcCtD
Carbidopa—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000545	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.71e-05	0.00578	CbGpPWpGaD
Carbidopa—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000508	CcSEcCtD
Carbidopa—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000494	CcSEcCtD
Carbidopa—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000487	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	7.77e-05	0.00516	CbGpPWpGaD
Carbidopa—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000471	CcSEcCtD
Carbidopa—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.44e-05	0.000456	CcSEcCtD
Carbidopa—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.000438	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	7.11e-05	0.00472	CbGpPWpGaD
Carbidopa—Rash—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000434	CcSEcCtD
Carbidopa—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000434	CcSEcCtD
Carbidopa—Headache—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000432	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.04e-05	0.00467	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GCLC—chronic obstructive pulmonary disease	6.96e-05	0.00462	CbGpPWpGaD
Carbidopa—Nausea—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000409	CcSEcCtD
Carbidopa—DDC—Metabolism—CTGF—chronic obstructive pulmonary disease	6.35e-05	0.00422	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.85e-05	0.00388	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.88e-05	0.00324	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.81e-05	0.00319	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.48e-05	0.00298	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.00282	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALB—chronic obstructive pulmonary disease	2.89e-05	0.00192	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NOS3—chronic obstructive pulmonary disease	2.76e-05	0.00183	CbGpPWpGaD
